安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Israeli medical breakthrough: a new treatment for blood cancer
Doctors at Rabin Medical Center successfully deploy homegrown CAR-T therapy for multiple myeloma The post Israeli medical breakthrough: a new treatment for blood cancer appeared first on JNS org
- What’s New in Blood Cancer Research and Treatment?
When Dr Sekeres first started treating blood cancer patients 20 years ago, it was the dawn of the field’s focus on individual tumor genetics, he said Understanding how mutations in a patient’s cancer cells drive tumors’ behavior and responses to treatment was key to unlocking today’s field of precision oncology, where targeted therapies are matched to patients’ individual cancers
- New Approvals Advancing Blood Cancer Medicine - PMC
Between July 1, 2023 and June 30, 2024, the FDA made several decisions that are providing new treatment options to patients with blood cancers Newly approved therapeutics, expansions of previously approved therapeutics for a new blood cancer type, and newly defined clinical trial endpoints for blood cancers are listed
- FDA Approves New Drug to Treat Advanced AML in Adults
PedAL is designed to connect children with new and more effective treatments and accelerate future medical advances Cancer treatments are usually evaluated in adults first and if successful, then children This has resulted in a nearly decade-long delay between when therapies are first available for adults compared to children
- Stanford Medicine-led trial leads to FDA approval of drug for . . .
Blood Cancers August 27, 2025 Stanford Medicine-led trial leads to FDA approval of drug for rare, deadly blood cancer By Krista Conger Fewer than half of people diagnosed with a subtype of myeloid lymphoid neoplasms are alive one year later A multicenter Phase 2 trial led by Stanford Medicine leads to FDA approval of new drug treatment
- Advances in Blood Cancer | AACR Cancer Progress Report 2025
A Decade of Progress: Transformative Advances in Blood Cancer Research and Treatment In this section, you will learn: Blood cancers, or hematologic malignancies, make up a large group of cancers that originate from blood-forming tissues
- As blood cancer treatments evolve, so does the patient journey
New cases of blood cancers — leukemia, lymphoma and myeloma — were expected to account for nearly 10% of new cancer cases diagnosed in the U S in 2020 Drug treatments for blood cancers have evolved In the past, myeloma patients received two drugs in sequence — two after two
- Blood Cancer Treatment in 2025: How to Make Informed Choices . . .
Blood cancers, including leukemia, lymphoma, and myeloma, require specialized treatment plans Chemotherapy and radiation are still widely used, but treatments have evolved significantly over the years In 2025, immunotherapy, CAR T-cell therapy, and targeted therapies are revolutionizing how doctors treat blood cancer These treatments are designed to be more effective while reducing the side
|
|
|